The MIT Koch Institute for Integrative Cancer Research is a hub of cancer research on the MIT campus, bringing together scientists and engineers to advance the fight against cancer. Established in 2008, it is a National Cancer Institute-designated Basic Cancer Research Center that focuses on five critical research areas: nanotechnology-based cancer therapeutics, detection and monitoring, metastasis, precision cancer medicine, and cancer immunology and immunotherapy. The institute fosters interdisciplinary collaboration among biologists, chemists, engineers, computer scientists, clinicians, and other experts. Located in the United States, the Koch Institute works in close collaboration with NCI-designated clinical cancer centers and biotech/pharma partners to develop novel insights, tools, and technologies for the detection, treatment, and prevention of cancer.
There is no investment information
No recent news or press coverage available for MIT Koch Institute for Integrative Cancer Research.